Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003?￠??2013

Yi-Ning Cheng; Neha S. Shah; Pennan M. Barry; Ed Desmond; SY Grace Lin; Gisela Schecter

首页> 外文期刊>Open Forum Infectious Diseases >Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003?￠??2013

【24h】

Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003?￠??2013

机译：加利福尼亚对利福平耐药性的分子和基于生长的检测方法不一致对结核病治疗结果的临床影响，2003年，2013年

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

cannot no abstract right now, maybe has no abstract or it's too hard to get

机译：现在不能没有摘要，可能没有摘要，或者太难获取

著录项

来源
《Open Forum Infectious Diseases》 |2016年第3期|共页
作者
Yi-Ning Cheng; Neha S. Shah; Pennan M. Barry; Ed Desmond; SY Grace Lin; Gisela Schecter;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. How should discordance between molecular and growth-based assays for rifampicin resistance be investigated? [J] . Hofmann-Thiel S., Hoffmann H., Hillemann D., The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease . 2017,第7期

机译：如何研究分子和生长的基于利福平抗性的分子和生长的测定之间的一种不等调？
2. Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis [J] . Park Shinhee, Jo Kyung-Wook, Lee Sang Do, Respiratory medicine . 2017,第期

机译：利福平 - 单抗性或利福平不良事件肺结核患者利福平滥本治疗治疗方法：回顾性队列队列分析
3. Evaluation of genotype MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex strains and clinical samples [J] . Spatharaki Paraskevi, Kontos Fanourios, Mavromanolakis Dimitrios, International journal of molecular medicine . 2015,第Suppla1期

机译：基因型MTBDRplus检测用于结核分枝杆菌复杂菌株和临床样品中利福平和异烟肼耐药性分子检测的评估
4. Molecular Genetic Analysis of Nucleotide Polymorphisms Associated with Rifampin and Isoniazid Resistance in Human Isolates of Mycobacterium tuberculosis [C] . Dorina Banica, Emilia Cazacu, Dan Otelea, International Symposium on Communications, Control and Signal Processing . 2008

机译：分枝杆菌结核病人分离株核苷酸多态性核苷酸多态性的分子遗传分析
5. Analysis of Mycobacterium tuberculosis in the state of Texas for rifampin resistance using molecular beacons. [D] . Bordt, Andrea S. 2008

机译：使用分子信标分析德克萨斯州结核分枝杆菌对利福平的耐药性。
6. Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance California 2003–2013 [O] . Neha S. Shah, SY Grace Lin, Pennan M. Barry, 2016

机译：2003-2013年加利福尼亚州对利福平耐药的分子检测和基于生长的检测方法不一致对结核病治疗结果的临床影响
7. Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003–2013 [O] . Neha S. Shah, SY Grace Lin, Pennan M. Barry, 2016

机译：加利福尼亚州利福平抗性分子和生长基于分子和生长测定的结核治疗结果的临床影响，2003 - 2013年

Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003?￠??2013

摘要

著录项

相似文献

相关主题

期刊订阅